In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
Choosing a fitness tracker can be intimidating, especially when starting your first fitness routine. There's a range of ...
Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...
The increases were particularly marked among middle-aged men, Black adults, residents of Midwestern states and ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
He said the company requires providers to document in its medical record and carefully monitors the quality of care ... which ...